First Light Asset Management, LLC
Top Portfolio Positions
35 positions ·
$1,176,236,598 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| AXGN |
Axogen, Inc.
Healthcare
|
4,002,768 | $132,611,703 | 11.27% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
980,758 | $122,251,484 | 10.39% | |
| NEO |
Neogenomics Inc
Healthcare
|
9,729,978 | $72,196,436 | 6.14% | |
| NPCE |
NeuroPace Inc
Healthcare
|
5,415,389 | $71,212,364 | 6.05% | |
| SIBN |
SI-BONE, Inc.
Healthcare
|
5,353,190 | $67,610,789 | 5.75% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
1,560,991 | $62,002,562 | 5.27% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
576,684 | $48,539,492 | 4.13% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
3,190,645 | $44,349,965 | 3.77% | |
| TLSI |
TriSalus Life Sciences, Inc.
Healthcare
|
10,440,944 | $41,763,776 | 3.55% | |
| TWST |
Twist Bioscience Corp
Healthcare
|
878,848 | $41,762,856 | 3.55% |
Portfolio Trend
25 quarters · across all stocks
Holdings in ATRC
Shares Held
Position Value (USD)
25 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,813,234 | 729,521 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $46,500,604 | 1,175,445 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $31,385,260 | 890,362 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $33,267,120 | 1,015,170 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $42,412,802 | 1,314,718 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $60,179,393 | 1,969,221 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $52,309,629 | 1,865,536 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $44,736,287 | 1,964,703 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $42,066,601 | 1,382,860 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $48,161,620 | 1,349,443 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $65,236,026 | 1,489,407 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $72,146,303 | 1,461,635 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $60,477,912 | 1,459,057 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $64,462,571 | 1,452,514 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $58,441,010 | 1,494,655 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $60,457,518 | 1,479,626 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $89,627,204 | 1,364,812 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $69,876,885 | 1,004,989 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $45,012,203 | 647,192 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $61,304,240 | 772,775 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $54,250,691 | 828,002 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $45,054,287 | 809,310 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $22,384,618 | 561,018 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $24,262,301 | 539,762 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $25,219,976 | 750,818 | Shares | Sole | 2020-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||